Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Semaglutide
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Phase IV
Recipient : Ali Aminian
Deal Size : Inapplicable
Deal Type : Inapplicable
Bariatric Surgery vs. Semaglutide vs. Tirzepatide
Details : Undisclosed
Product Name : Undisclosed
Product Type : Peptide
Upfront Cash : Inapplicable
January 31, 2025
Lead Product(s) : Semaglutide
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Phase IV
Recipient : Ali Aminian
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 21, 2017
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
The EVICEL® Neurosurgery Phase III Study
Details : Undisclosed
Product Name : Evicel
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 29, 2015
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
The Paediatric EVICEL® Neuro Study
Details : Undisclosed
Product Name : Evicel
Product Type : Undisclosed
Upfront Cash : Inapplicable
December 05, 2014
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Hematology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
The Paediatric EVICEL® Soft Tissue and Parenchymal Organ Bleeding Study
Details : Undisclosed
Product Name : Evicel
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 28, 2014
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Hematology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Hematology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 28, 2014
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Hematology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Thrombin
Therapeutic Area : Hematology
Study Phase : Phase IV
Sponsor : Johnson & Johnson
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
March 24, 2014
Lead Product(s) : Thrombin
Therapeutic Area : Hematology
Highest Development Status : Phase IV
Sponsor : Johnson & Johnson
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
The Fibrin Pad CV Phase III Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 20, 2014
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Thrombin
Therapeutic Area : Hematology
Study Phase : Phase IV
Sponsor : Johnson & Johnson
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase IV Bioseal Study in Brain Tumor Surgery
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 14, 2014
Lead Product(s) : Thrombin
Therapeutic Area : Hematology
Highest Development Status : Phase IV
Sponsor : Johnson & Johnson
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Hematology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
The EVARREST® Fibrin Sealant Patch Liver Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
November 25, 2013
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Hematology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable